MedPath

Strategic Ingestion of Creatine Supplementation and Resistance Training in Trained Young Adults

Not Applicable
Recruiting
Conditions
Strength
Muscle
Registration Number
NCT06438887
Lead Sponsor
University of Regina
Brief Summary

Creatine supplementation improves measures of muscle accretion and performance compared to placebo during a resistance training program. However, the optimal creatine supplementation protocol for maximizing these improvements is unknown.

Detailed Description

Creatine is a naturally occurring nitrogen containing compound endogenously produced in the body through reactions involving the amino acids arginine, glycine and methionine. Alternatively, creatine can be consumed in the diet (primarily from red meat and seafood) or through commercially manufactured creatine. It has been proposed that the strategic ingestion of creatine supplementation may be an important factor to consider during a resistance training program to increase muscle growth and performance. There is evidence that creatine supplementation only on training days has greater muscle benefits compared to placebo in healthy older adults. However, the effects of creatine on training days (compared to creatine on non-training days or placebo) in healthy young adults is unknown. Further, pre- and post-exercise creatine supplementation appears to produce similar muscle benefits (compared to placebo) in healthy older adults. It remains to be determined whether the timing of creatine ingestion (immediately before vs. immediately following training sessions) influences the physiological adaptations from resistance training compared to placebo in young healthy adults. It is also unknown whether differences exist in supplementing with creatine immediately before, during or immediately following resistance training sessions in young healthy adults.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Physically active (performing structured resistance training > 2x/week for ≥ 4 weeks)
  • Males and females (age 18-39)
Exclusion Criteria
  • Pregnant or nursing
  • Have consumed creatine monohydrate within 30 days prior to the start of the study
  • Pre-existing allergies to the placebo

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Body Compositionbaseline, week 16

Whole-body lean mass (kg) using bioelectrical impedance analysis

Endurancebaseline, week 16

Repetitions to fatigue for leg press and chest press (total number)

Muscle Hypertrophybaseline, week 16

Muscle thickness of the biceps, triceps, quadriceps, hamstrings and calf muscle using B-mode ultrasound (cm)

Powerbaseline, weekn 16

Vertical jump (watts)

Hydrationbaseline, week 16

Total body water (kg) using bioelectrical impedance analysis

Strengthbaseline, week 16

1-repetition maximum leg press and chest press (kg)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Regina

🇨🇦

Regina, Canada

University of Regina
🇨🇦Regina, Canada
Darren G Candow, PhD
Principal Investigator
Darren Candow
Contact
Darren.Candow@uregina.ca

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.